Yale Cancer Center

STING Agonist Plays New Role in Head and Neck Cancer Therapy

The Yale Cancer Center has discovered a new role for Stimulator of Interferon Genes...

Checkpoint Inhibitor Increases Head and Neck Cancer Survival Time

The checkpoint inhibitor pembrolizumab (Keytruda) offers patients with advanced head and neck cancers longer...

Reduced Radiation Improves Outcomes for HPV-Positive Oropharynx Cancer Patients

Oropharynx cancers that test positive for the human papillomavirus (HPV) have been rising. After...